Monitoring Unfractionated Heparin Therapy with Antifactor Xa Activity Results in Fewer Monitoring Tests and Dosage Changes than Monitoring with the Activated Partial Thromboplastin Time-Reference-Cited by-同舟云学术

Monitoring Unfractionated Heparin Therapy with Antifactor Xa Activity Results in Fewer Monitoring Tests and Dosage Changes than Monitoring with the Activated Partial Thromboplastin Time

Published:1999-06 Issue:6 Volume:19 Page:760-766
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Rosborough Terry K.

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. The heterogeneity of the anticoagulant response to heparin

2. Heparin kinetics in venous thrombosis and pulmonary embolism.

3. Heparin Pharmacokinetics: Increased Requirements in Pulmonary Embolism

4. Heparin Therapy Adjusted for Body Weight

5. Measurement of Blood Heparin Levels - variation in Results with Assay Method

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism;International Journal of Laboratory Hematology;2023-11-21

2. Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study;Journal of Intensive Care;2023-11-16

3. Comparison of Time Within Therapeutic Range Using Anti-Factor Xa Versus Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin in Children;The Journal of Pediatric Pharmacology and Therapeutics;2023-05-01

4. An Overview of Heparin Monitoring with the Anti-Xa Assay;Methods in Molecular Biology;2023

5. Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay;International Journal of Molecular Sciences;2022-09-23